O Timofeev, P Giron, S Lawo, M Pichler… - NPJ Precision …, 2024 - nature.com
At least 40% of human cancers are associated with aberrant ERK pathway activity (ERKp). Inhibitors targeting various effectors within the ERKp have been developed and explored for …
P Chen, Y Chen, A Sharma, AGC Maria… - Cellular …, 2025 - Elsevier
Colorectal cancer (CRC) is one of the most common types of cancer with high incidence and mortality. Endoplasmic reticulum oxidoreductase 1 alpha (ERO1L) is overexpressed in CRC …
The mitogen-activated protein kinase (MAPK)/ERK and phosphatidylinositol-3 kinase (PI3K)/AKT pathways are dysregulated in various human cancers, including pancreatic …
T Takasaki, Y Hamabe, K Touchi… - Oxidative Medicine …, 2024 - Wiley Online Library
The extracellular signal‐regulated kinase (ERK) MAPK pathway is dysregulated in various human cancers and is considered an attractive therapeutic target for cancer. Therefore …
Endometrial cancer is the most common gynecological cancer that affects the female reproductive organs. The standard therapy for EC for the past two decades has been …
Six benzhydrol analogues were successfully synthesised and evaluated for their antiproliferative effect on breast cancer cells. These compounds were designed based on …
GI Khandakar, Y Miyamoto, R Satoh… - Genes to …, 2023 - Wiley Online Library
The extracellular‐signal‐regulated‐kinase (ERK) signaling pathway is essential for cell proliferation and is frequently deregulated in human tumors such as pancreatic cancers …
The copy of this thesis has been supplied on the condition that anyone who consults it, is understood to recognize that the copyright of this work rests with the author, namely Mr Umar …